Deepu Madduri | Mount Sinai

About Me

Deepu Madduri, MD, is Adjunct Assistant Professor of Medicine (Hematology and Medical Oncology) at The Tisch Cancer Institute and Icahn School of Medicine at Mount Sinai and Senior Medical Director at Janssen Oncology. Dr. Madduri has expertise in plasma cell disorders including multiple myeloma, amyloid light-chain amyloidosis, POEMS syndrome, plasmacytoma, and monoclonal gammopathies of undetermined significance (MGUS).

Dr. Madduri’s research has included first-in-human/phase 1 clinical trial studies involving immunotherapy with checkpoint inhibitors and immune effector cells such as CAR T-cell therapy, NK-cell therapy, and Bi-specific antibodies. She has played an integral role in initiating CAR T-cell studies for multiple myeloma.

Dr. Madduri received her MD from the College of Medicine at the University of Oklahoma. She completed a residency in Internal Medicine at St. Mary Medical Center in Langhorne, Pennsylvania, and a fellowship in Hematology and Oncology at the University of California, Harbor Campus in Torrance, California, with additional fellowship training in Blood and Marrow Transplant at Stanford Hospital.

Language

English

Position

ADJUNCT ASSISTANT PROFESSOR | Medicine, Hematology and Medical Oncology

About Me

Deepu Madduri, MD, is Adjunct Assistant Professor of Medicine (Hematology and Medical Oncology) at The Tisch Cancer Institute and Icahn School of Medicine at Mount Sinai and Senior Medical Director at Janssen Oncology. Dr. Madduri has expertise in plasma cell disorders including multiple myeloma, amyloid light-chain amyloidosis, POEMS syndrome, plasmacytoma, and monoclonal gammopathies of undetermined significance (MGUS).

Dr. Madduri’s research has included first-in-human/phase 1 clinical trial studies involving immunotherapy with checkpoint inhibitors and immune effector cells such as CAR T-cell therapy, NK-cell therapy, and Bi-specific antibodies. She has played an integral role in initiating CAR T-cell studies for multiple myeloma.

Dr. Madduri received her MD from the College of Medicine at the University of Oklahoma. She completed a residency in Internal Medicine at St. Mary Medical Center in Langhorne, Pennsylvania, and a fellowship in Hematology and Oncology at the University of California, Harbor Campus in Torrance, California, with additional fellowship training in Blood and Marrow Transplant at Stanford Hospital.

Language

English

Position

ADJUNCT ASSISTANT PROFESSOR | Medicine, Hematology and Medical Oncology

Clinical Focus

Multiple Myeloma

Publications

Publications:43

Selected Publications

View All Publications

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Dr. Madduri did not report having any of the following types of financial relationships with industry during 2022 and/or 2023: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.